2005
DOI: 10.1128/mcb.25.12.5282-5291.2005
|View full text |Cite
|
Sign up to set email alerts
|

G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
102
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 123 publications
(113 citation statements)
references
References 65 publications
11
102
0
Order By: Relevance
“…Cytoplasmic localization of p21 has been reported to correspond with a poor clinical outcome of patients with breast cancer 95,96 , which could therefore be explained by the observation that besides losing its CDK-inhibitory function, cytoplasmic p21 also gains anti-apoptotic functions 93,94 . Consistent with its role in resistance to apoptosis, ectopic expression of p21 prevents anoikis (detachment-induced apoptosis) 97 . Consequently, complete loss of p21 function is predicted to provide a selective disadvantage to cancer cells, as it could result in a lower apoptotic threshold.…”
Section: Is P21 Required For Oncogenic Transformation?mentioning
confidence: 79%
“…Cytoplasmic localization of p21 has been reported to correspond with a poor clinical outcome of patients with breast cancer 95,96 , which could therefore be explained by the observation that besides losing its CDK-inhibitory function, cytoplasmic p21 also gains anti-apoptotic functions 93,94 . Consistent with its role in resistance to apoptosis, ectopic expression of p21 prevents anoikis (detachment-induced apoptosis) 97 . Consequently, complete loss of p21 function is predicted to provide a selective disadvantage to cancer cells, as it could result in a lower apoptotic threshold.…”
Section: Is P21 Required For Oncogenic Transformation?mentioning
confidence: 79%
“…In fact, despite the cytoplasmic vesicle-like staining of p53 in Noc-treated cells, the cellular morphology was different from control cells (Figure 3b). To exclude this possibility, we pre-treated Aphidicolin (Aph; Collins et al, 2005) to block the cell cycle at the G1 phase and monitored the effect of Noc on the expression of p53. Similar to our earlier result, Noc blocked p53 reduction ( Figure 3c).…”
Section: Resultsmentioning
confidence: 99%
“…This is the first report that SKP2 is involved in anoikis resistance. Given the report of Collins et al (27) that overexpression of p27 conferred anoikis resistance in MCF-10A cells and p27 is one of the most important substrates for SKP2, we also detected the effect of p27 on anoikis. The results showed that knockdown of p27 had no effect on anoikis in EC9706 cells, suggesting the effect of SKP2 on anoikis in ESCC was not mediated by p27.…”
Section: Discussionmentioning
confidence: 98%
“…Kim et al (28) proposed that galectin-3 inhibition of anoikis involves cell cycle arrest at an anoikis-insensitive point (late G 1 ) through modulation of gene expression and activities of cell cycle regulators. Collins et al (27) also reported that G 1 -S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. However, our results showed that SKP2 knockdown had no effect on cell cycle progress of EC9706 cells during induction of anoikis on polyHEMA plates.…”
Section: Discussionmentioning
confidence: 99%